Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled trial of Wangbi capsule in knee osteoarthritis
CTR20244590Phase 2Completed
- Sponsor
- China Resources Benxi Sanyao
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Wangbi in knee osteoarthritis (OA), sponsored by China Resources Benxi Sanyao. Started Dec 2024; status: completed.
02
Drugs
Wangbi
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on CTR20244590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20244590.